Back to BlackRock, Inc. BlackRock, Inc.

CHRSCHRS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in COHERUS ONCOLOGY INC

Yes. BlackRock holds 12,003,316 shares of CHRS (Coherus Oncology), worth $16.8M, as of its Q2 2026 13F filing. It increased the position by 1,638,242 shares (+15.8%) from Q1 2026. BlackRock has held CHRS in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$16.8M

Current Shares

12M

Total Value Change

+$4.4M

Total Shares Change

+51,363

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12M
+15.8%
$16.8M0.0%$1.40
33
2026-Q1
Decreased
10.4M
-1.9%
$17.5M0.0%$1.69
0
2025-Q4
Increased
10.6M
+1.0%
$15M0.0%$1.42
28
2025-Q3
Decreased
10.5M
-2.6%
$17.2M0.0%$1.64
0
2025-Q2
Decreased
10.7M
-2.2%
$7.9M0.0%$0.73
0
2025-Q1
Decreased
11M
-0.9%
$8.9M0.0%$0.81
0
2024-Q4
Decreased
11.1M
-7.3%
$15.3M0.0%$1.38
0
2024-Q3
First report
12M
-
$12.4M0.0%$1.04
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used